Google AI
The Times Australia

Times Media

Takeda Ukraine & Bulgaria Earn #8 Global Ranking in Best Places to Work 2024

LONDON, UK - Media OutReach Newswire - 5 June 2025 - Takeda, a global value-based, R&D-driven biopharmaceutical company, has been proudly recognized as one of the Top 10 Best Places to Work in the World for 2024, achieving the No.

8 global ranking by both Ukraine and Bulgaria countries. This prestigious recognition underscores Takeda's commitment to creating a workplace that embraces diversity, equity and inclusion (DE&I), fostering an empowering culture across all locations it operates. This accolade reflects Takeda's consistent focus on employee well-being, trust-based leadership, and a people-centered approach to business.

At Takeda, we are committed to delivering an exceptional employee experience by cultivating an inclusive, purpose-driven workplace where our people can grow both personally and professionally. Being recognized as a Best Place to Work reflects our unwavering dedication to building a culture where every colleague feels valued, supported, and empowered to thrive.

Volodymyr Pedko, General Manager of Takeda Ukraine, shared:
"It gives me great pride to receive this recognition during such challenging times! It stands as a testament to the exceptional quality of work and everyone's commitment to building and sustaining an innovative and inclusive workplace in our organization."

Todor Kesimov, General Manager of Takeda Romania & Bulgaria, commented:
"I am extremely proud that Takeda has been recognized as one of the top ten employers in the world for 2024. This confirms our efforts to build a culture of trust, care, and respect in every country, including Bulgaria. This recognition inspires us to continue building a better future – for our employees, for patients, and for society."
Hashtag: #BestPlacesToWork


The issuer is solely responsible for the content of this announcement.

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit .

For more information, please visit the program website: .

Times Magazine

The $4,699 iPhone: why people still want Apple’s best

The iPhone 18 Pro Max can cost more than many people would spend on a computer. Its appeal says as...

BYD Shark 6 v Toyota LandCruiser 300: can new technology defeat an Australian legend?

The BYD Shark 6 and Toyota LandCruiser 300 Series may appear to belong in different vehicle catego...

Technology

MISSION 1, MISSION 1 PRO and MISSIO…

Today, GoPro, Inc. (NASDAQ: GPRO) announced that its MISSION 1 Series of compact cinema cameras ha...

Local News

Fitstop Global Games to Bring 1,000…

The Australian-born fitness brand is bringing its global competition home, with athletes from across...

Culture

Retail therapy: Do shops sell us things — or …

There is a particular pleasure in buying something new. It might be a pair of shoes, a television...

Travel

School holiday pricing: fair market economics…

Every Australian family with school-aged children knows the pattern. Look at an airfare, hotel ro...

The Times Features

Retail therapy: Do shops sell us things — or dreams?

There is a particular pleasure in buying something new. It might be a pair of shoes, a television...

Shipstern Bluff surfing movie

STERN FEVER is a new independent feature length documentary telling the story of Shipstern Bluff, ...

$1 Million of Free Care to Help Older Australians Falli…

Almost 154,000 older Australians are waiting to receive all of the in-home aged care funding they ...